BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Profectus BioSciences, Inc. 

1450 South Rolling Road

Baltimore  Maryland  21227  U.S.A.
Phone: 443-543-5011 Fax: 443-543-5013


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
Profectus BioSciences, Inc. Nabs $9.5 Million Government Grant 10/31/2014 7:21:14 AM
Profectus BioSciences, Inc. Receives Department Of The Army Funding For Studies Directed Toward The Development Of A VesiculoVax™ rVSV-Vectored Vaccine For Ebola And Marburg Viruses 10/22/2014 7:01:47 AM
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies 10/22/2014 6:57:00 AM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
HHS Contracts With Profectus BioSciences, Inc. To Manufacture Ebola Vaccine For Animal Safety Studies 10/19/2014 6:56:48 PM
Profectus BioSciences, Inc. Awarded $3.5M National Institutes of Health (NIH) SBIR Grants To Advance Therapeutic Vaccines Against HIV 7/29/2014 9:19:06 AM
Profectus BioSciences, Inc. Presents Data at Filovirus Medical Countermeasures Meeting Showing That a Single Dose of VSV-Vectored Vaccine Completely Protects Monkey Against Challenge With Ebola and Marburg Viruses 9/24/2013 9:56:41 AM
Profectus BioSciences, Inc. Announces Initiation of Clinical Trial Evaluating its Therapeutic HIV Vaccine in Support of the “Cure Agenda” 9/17/2013 10:06:33 AM
Althea Technologies, Inc. & Profectus BioSciences, Inc. Sign Manufacturing Agreement for Plasmid DNA Production 2/26/2013 9:32:33 AM
Profectus BioSciences, Inc.'s Vesicular Stomatitis Virus-Vectored HIV-1 Vaccine Safe and Immunogenic in Government Sponsored Phase 1 Trial 12/4/2012 10:35:53 AM
1234